Abstract 10669: Phenytoin, an Anti-Epileptic Sodium Channel Blocker, May Be a Novel Therapy for Type 3 Long Qt Syndrome Mediated by the Lidocaine-Insensitive SCN5A-F1760C Variant
Year: 2022
Type: conference-abstract
Source: Circulation
Authors: Dan Ye, Marissa Stutzman, Maengjo Kim, Martina Gluscevic, Wei Zhou, Xiaozhi Gao, David J Tester, John Giudicessi, Kevin Shannon, Michael J Ackerman
Institutions: Mayo Clinic, University of California, Los Angeles
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4380793499